PL2144924T3 - Szczepionka z białkiem fuzyjnym - Google Patents
Szczepionka z białkiem fuzyjnymInfo
- Publication number
- PL2144924T3 PL2144924T3 PL08724181T PL08724181T PL2144924T3 PL 2144924 T3 PL2144924 T3 PL 2144924T3 PL 08724181 T PL08724181 T PL 08724181T PL 08724181 T PL08724181 T PL 08724181T PL 2144924 T3 PL2144924 T3 PL 2144924T3
- Authority
- PL
- Poland
- Prior art keywords
- fusion protein
- protein vaccine
- vaccine
- fusion
- protein
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 229940023143 protein vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0700919 | 2007-04-16 | ||
US94047307P | 2007-05-29 | 2007-05-29 | |
EP08724181.6A EP2144924B1 (en) | 2007-04-16 | 2008-04-14 | Fusion protein vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2144924T3 true PL2144924T3 (pl) | 2017-06-30 |
Family
ID=39864173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08724181T PL2144924T3 (pl) | 2007-04-16 | 2008-04-14 | Szczepionka z białkiem fuzyjnym |
Country Status (15)
Country | Link |
---|---|
US (1) | US8313748B2 (pl) |
EP (1) | EP2144924B1 (pl) |
CN (1) | CN101855238B (pl) |
CA (1) | CA2684494C (pl) |
CY (1) | CY1117896T1 (pl) |
DK (1) | DK2144924T3 (pl) |
ES (1) | ES2586418T3 (pl) |
HR (1) | HRP20160995T1 (pl) |
HU (1) | HUE028253T2 (pl) |
LT (1) | LT2144924T (pl) |
PL (1) | PL2144924T3 (pl) |
PT (1) | PT2144924T (pl) |
RU (1) | RU2487890C2 (pl) |
SI (1) | SI2144924T1 (pl) |
WO (1) | WO2008127179A1 (pl) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014018904A1 (en) * | 2012-07-26 | 2014-01-30 | Genocea Biosciences, Inc. | Fused antigen vaccines and compositions against streptococcus pneumoniae |
CN104717977A (zh) | 2012-10-03 | 2015-06-17 | 诺华股份有限公司 | 免疫原性组合物 |
CN103694323B (zh) * | 2013-12-09 | 2017-01-18 | 成都欧林生物科技股份有限公司 | 金黄色葡萄球菌MntC重组蛋白及其制备方法和应用 |
CN108135992A (zh) * | 2015-10-21 | 2018-06-08 | 米纳瓦克斯有限责任公司 | 免疫原性融合蛋白 |
CA3004631A1 (en) * | 2015-12-30 | 2017-07-06 | Minervax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
CA3066020A1 (en) | 2017-06-16 | 2018-12-20 | Glaxosmithkline Biologicals Sa | Method of treatment |
CA3161857A1 (en) | 2019-11-22 | 2021-05-27 | Glaxosmithkline Biologicals Sa | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
US20230303637A1 (en) | 2020-06-12 | 2023-09-28 | Glaxosmithkline Biologicals Sa | Gbs ferritin nanoparticles |
WO2021250626A2 (en) | 2020-06-12 | 2021-12-16 | Glaxosmithkline Biologicals Sa | Dock tag system |
EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
CN114437235B (zh) * | 2022-01-04 | 2024-02-09 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 |
CN116478953B (zh) * | 2023-06-14 | 2023-09-12 | 四川大学华西医院 | 鲍曼不动杆菌DlaT重组蛋白、制备方法及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4225579A (en) * | 1979-02-27 | 1980-09-30 | Israel Kleinberg | Means and method for improving defenses against caries |
US4496538A (en) | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
US4879213A (en) * | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
WO1994001031A1 (fr) | 1992-07-02 | 1994-01-20 | Paul Charvet | Appareil de cuisson dans l'huile a chauffage au gaz |
CA2123579C (en) | 1992-09-16 | 2005-05-10 | James B. Dale | Recombinant multivalent m protein vaccine |
IL107458A0 (en) | 1992-11-02 | 1994-02-27 | Gen Hospital Corp | Conjugate vaccine against group b streptococcus |
ATE240351T1 (de) | 1993-03-19 | 2003-05-15 | Gunnar Lindahl | Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei) |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
AU2004219910B2 (en) * | 2003-03-13 | 2010-06-17 | Glaxosmithkline Biologicals S.A. | Purification process for bacterial cytolysin |
EP1663303B1 (en) | 2003-09-15 | 2011-05-04 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions for streptococcus agalactiae |
-
2008
- 2008-04-14 PT PT87241816T patent/PT2144924T/pt unknown
- 2008-04-14 RU RU2009142976/10A patent/RU2487890C2/ru active
- 2008-04-14 DK DK08724181.6T patent/DK2144924T3/en active
- 2008-04-14 EP EP08724181.6A patent/EP2144924B1/en active Active
- 2008-04-14 WO PCT/SE2008/000270 patent/WO2008127179A1/en active Application Filing
- 2008-04-14 US US12/596,249 patent/US8313748B2/en active Active
- 2008-04-14 CA CA2684494A patent/CA2684494C/en active Active
- 2008-04-14 CN CN200880020390.1A patent/CN101855238B/zh active Active
- 2008-04-14 PL PL08724181T patent/PL2144924T3/pl unknown
- 2008-04-14 SI SI200831661A patent/SI2144924T1/sl unknown
- 2008-04-14 ES ES08724181.6T patent/ES2586418T3/es active Active
- 2008-04-14 HU HUE08724181A patent/HUE028253T2/en unknown
- 2008-04-14 LT LTEP08724181.6T patent/LT2144924T/lt unknown
-
2016
- 2016-08-08 HR HRP20160995TT patent/HRP20160995T1/hr unknown
- 2016-08-09 CY CY20161100783T patent/CY1117896T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT2144924T (pt) | 2016-08-17 |
RU2487890C2 (ru) | 2013-07-20 |
SI2144924T1 (sl) | 2016-12-30 |
ES2586418T3 (es) | 2016-10-14 |
WO2008127179A1 (en) | 2008-10-23 |
CA2684494C (en) | 2016-07-05 |
CN101855238B (zh) | 2014-09-17 |
US8313748B2 (en) | 2012-11-20 |
CY1117896T1 (el) | 2017-05-17 |
DK2144924T3 (en) | 2016-08-22 |
LT2144924T (lt) | 2016-10-10 |
WO2008127179A8 (en) | 2009-07-23 |
EP2144924A1 (en) | 2010-01-20 |
EP2144924A4 (en) | 2010-08-25 |
US20100062015A1 (en) | 2010-03-11 |
HUE028253T2 (en) | 2017-02-28 |
CN101855238A (zh) | 2010-10-06 |
CA2684494A1 (en) | 2008-10-23 |
RU2009142976A (ru) | 2011-05-27 |
HRP20160995T1 (hr) | 2016-10-21 |
EP2144924B1 (en) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219490A1 (zh) | 免疫球蛋白融合蛋白 | |
IL196889A0 (en) | Albumin-insulin fusion proteins | |
EP2144924A4 (en) | FUSION PROTEIN VACCINE | |
IL204839A0 (en) | Albumin fusion proteins | |
IL219048A (en) | Peptide compounds derived from urcl10 | |
SI3118220T1 (sl) | Protein | |
EP2173377A4 (en) | ANTIBODY-ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS | |
ZA200906699B (en) | Insecticidal proteins | |
IL205716A0 (en) | Formulations for taci-immunoglobulin fusion proteins | |
ZA201001029B (en) | Vaccines | |
GB0700135D0 (en) | Vaccine | |
GB0725201D0 (en) | Peptide fusion proteins | |
GB0719231D0 (en) | Protein | |
GB2465684B (en) | Biocidal fusion peptides | |
GB0700759D0 (en) | Novel fusion protein | |
GB0720563D0 (en) | Protein | |
GB0713169D0 (en) | Fusion proteins | |
GB0709707D0 (en) | Novel fusion protein | |
GB0713302D0 (en) | Protein | |
GB0719236D0 (en) | Protein | |
GB0716224D0 (en) | Peptides for vaccine | |
GB0715413D0 (en) | Fusion skyer | |
GB0715933D0 (en) | Fusion snicker | |
IL206541A0 (en) | Novel protein | |
GB0706825D0 (en) | Vaccine |